Introduction
Dendritic cells (DCs) originate from hematopoietic precursors and comprise specialized DC subtypes that differ in phenotype, function and localization. In humans, epidermal Langerhans cells (LCs), interstitial DCs and plasmacytoid DCs (pDCs) are recognized as separated DC lineages.
1-3 CD34 + progenitors from umbilical cord blood represent well-characterized model cells for studying human DC subset development and maturation in vitro. 4 The two myeloid-related human DC subtypes, LCs and interstitial DCs, co-develop from CD34 + cells in response to GM-CSF plus TNF stimulation, 5, 6 and TGF-1 addition polarizes precursors towards the LC pathway. 7, 8 Despite considerable knowledge on cytokine requirements and the identification of putative shared precursors of LC/DC and monocytes, 9 transcriptional processes underlying their development remain poorly defined. Retroviral gene transduction experiments revealed that CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors reciprocally control LC differentiation from CD34 + cells, 10 and the Id proteins Id2 and Id3 inhibit human pDC but not myeloid DC development from CD34 + progenitors. 11 However, little is known about processes that control human myeloid DC subset differentiation from putative shared precursors.
RelB is a member of the NF-B transcription factor family, which comprises 5 members in mammals. RelA (p65), c-Rel, RelB, NF-B1 (encoding the precursor molecule p100 and the processed form p52) and NF-B2
(encoding the precursor molecule p105 and the processed form p50). The different members can form a variety of homo-and heterodimers and are only.
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Similar to the I Bs, the precursor molecules p100 and p105 can sequester NF-B molecules in the cytoplasm via their ankyrin-rich C-terminal domains. 12 Recent studies have shown that two independent NF-B activation cascades differentially control the nuclear translocation of NF-B transcription factors.
13,14
The classical NF-B signaling cascade regulates dimers consisting of p65, c-Rel and p50 and induces phosphorylation and ubiquitin-dependent degradation of the I Bs (I B , I B and I B ). In contrast to p65, c-Rel and p50, RelB is not bound to the I Bs but is retained in the cytoplasm by p100.
15, 16 Processing of p100 to p52, which results in the translocation of p52/RelB dimers into the nucleus is induced by the non-classical NF-B signaling cascade.
RelB has previously been associated with mature DCs. [17] [18] [19] Furthermore,
RelB is upregulated and translocated into the nucleus of DCs in response to various stimuli that induce their maturation. [20] [21] [22] [23] [24] However, RelB function in human DC development or maturation has not been described. In mice, RelB is essential for the generation of a specific DC subset (CD11c /mL in 24 well plates (NUNC or Costar) in the presence of cytokines as described. 8 Briefly, serum free medium X-VIVO 15 (BioWhittaker, Walkersville, MD) was supplemented with L-glutamine (2.5 mmol/L), penicillin (125 U/mL) and streptomycin (125 U/mL). Cultures contained the following cytokine cocktail: GM-CSF (200 ng/mL), SCF (20 ng/mL), FLT3 ligand (FLT3L) (50 ng/mL), TNF-(2.5 ng/mL) and TGF-1 (0.1 or 0.5 ng/mL). Cultures were grown for the time periods indicated in the text and DC maturation was induced by addition of 500 ng/mL CD40 Ligand, (CD40L trimer), kindly provided by Immunex (Seattle, WA) for 48h.
Progenitor cell expansion cultures contained FLT3L, SCF and Thrombopoietin (TPO) each at 50ng/ml in above-described serum-free culture system. Monocyte generation cultures included macrophage-colony stimulating factor (M-CSF, only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From 100ng/ml), interleukin (IL)-6 (20 ng/ml), FLT3L (50 ng/ml) and SCF (20 ng/ml); granulocyte generation cultures contained granulocyte-colony stimulating factor (G-CSF, 100 ng/ml), SCF (50 ng/ml) and FLT3L (50 ng/ml). SCF, TPO, M-CSF, G-CSF and TNF-were purchased from PeproTech (London, UK); TGF-1 from R&D Systems GmbH (Wiesbaden, Germany); FLT3L was obtained from Amgen (Seattle, WA); GM-CSF and IL-6 was kindly provided by Novartis Research Institute (Vienna, Austria).
Retroviral constructs and gene transduction
The cDNAs of RelB (human; full length, obtained from R. Thomas, Brisbane, Australia), p100 N (aa 407-900 of the coding cDNA of p100, obtained from C.V.
Paya, Rochester, MN), and a super-repressor form of I B (S32/36A, obtained from R. de Martin, Vienna, Austria) were subcloned into the multiple cloning site of the Moloney Murine Leukemia Virus (MMuLV) based retroviral vector pBMN (obtained from G.P. Nolan, Stanford, CA), upstream of an internal ribosome entry site (IRES) followed by either enhanced green fluorescent protein (GFP) or murine CD8 (mCD8 ). To produce recombinant amphotropic retrovirus, vectors were transiently transfected into the packaging cell line Phoenix-GP (Gag-Pol) we inserted a 5xNF-B-GFP reporter cassette (obtained from R. deMartin, Vienna, Austria), followed by single cell cloning.
Immunofluorescence and flow cytometry
Immunofluorescence stainings were performed as previously described. 29 Murine monoclonal antibodies (mAbs) of the following specificities were used: 
Mixed leukocyte reaction (MLR)
Gene-transduced GFP + CD1a + cells were FACS sorted and -irradiated (25Gy). 
Western Blotting
Whole cell lysates of primary cells were prepared as follows: cells were pelleted, washed once with icecold phosphate-buffered saline (PBS), then resuspended in an appropriate volume of lysis-buffer (20 mM Tris pH7.5, 150 mM NaCl, 2.5 mM EDTA, 1% Triton X-100) supplemented with protease inhibitors (protease inhibitor cocktail set III, Calbiochem). After 15 min incubation on ice, extracts were centrifuged at 14000 rpm for 10 min at 4°C. U937 cells were transduced with above-described retroviral constructs and GFP + cells were sorted and expanded. Nuclear and cytoplasmic extracts were prepared using the nuclear extract kit from Active Motif, California CA, according to the manufacturer's instructions with an additional washing step of the isolated nuclei. The protein concentration of the extracts was determined by a Bradford based protein assay from Bio-Rad. For western blotting, 10-15 µg protein of the prepared extracts were resolved by SDS-PAGE (8-12%) and transferred to a PVDF membrane.
Immunoblotting was performed using the following rabbit polyclonal antibodies:
anti-RelB sc-226, anti-p65 sc-372, anti-cRel sc-272, anti-p52 sc-298 and anti-I B . sc-371. Goat polyclonal anti-actin sc-10806, rabbit polyclonal anti-histone H1 sc-1617 or rabbit anti-SP1 sc-59 were used to control loaded protein only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From amounts (Santa Cruz, Santa Cruz, CA). Detection was performed using HRP conjugated anti-rabbit IgG (Pierce Biotechnology, Rockland, IL) or HRP conjugated anti-goat IgG (Santa Cruz, Santa Cruz, CA) in combination with the chemiluminescent substrate SuperSignal (Pierce Biotechnology, Rockland, IL).
For detection of p100 N, rabbit serum against the C-terminal domain of p100 was used (N. Rice, Frederick, MD).
Statistics
Data are presented as mean values +/-standard deviation (SD). For comparisons, a 2-sided paired student t test was used. P values of less than 0.05 were considered statistically significant. upstream of IRES-GFP. We delivered p100 N, empty vector (= control), RelB or I B -SR into CD34 + progenitor cells and induced them to differentiate into DCs as described. 8 Overexpression of RelB in these primary cells was confirmed using immunofluorescence microscopy ( Fig. 1B) as well as by western blot analysis of FACS sorted GFP + gene-transduced cells (Fig. 1C) . Additionally, we transduced U937 cells with RelB-IRES-GFP or control constructs. Nuclear and cytoplasmic extracts of GFP + cells were analyzed (Fig. 1D ). As expected, high
RelB levels could be detected in the nuclear extracts of RelB transduced cells. In contrast, p100 N transduced primary cells showed a pronounced cytoplasmic
RelB localization (Fig. 1B) , consistent with its capacity to capture RelB in the only.
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15 Retroviral expression of p100 N was confirmed by western blot analysis of cytoplasmic extracts from U937 cells (Fig.1G ). Approximately two-fold I B overexpression levels were observed in GFP + I B -SR transduced primary cells (Fig. 1C) . As expected, I B -SR inhibited TNF -induced nuclear translocation of p65 in U937 cells (Fig. 1F) .
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Conversely, p100 N significantly inhibited generation of these CD11b + CD1a + cells ( Fig. 2A, Fig. 2C, right) . Total percentages of CD1a + cells were on average equivalent among p100 N versus control transduced cells, and RelB or p100 N did not influence cell proliferation (Fig. 4E ). These data suggest that RelB plays a pivotal role for the generation of CD11b 
Inhibition of RelB does not impair LC differentiation.
We found that inhibition of RelB by p100 N impairs the generation of CD11b I B SR and p100 N markedly differ in inhibitory effects on DCs.
We also included the classical NF-B pathway inhibitor I B -SR in our experiments. Percentages of I B -SR-IRES-GFP transduced cells gradually decreased during culture, whereas no such effect was observed for p100 N-IRES-GFP transduced cells (Fig. 4E, bar diagrams) . This effect of I B -SR was mediated by decreased cell proliferation rather than induction of apoptosis as evidenced from PKH26 dye labeling (Fig. 4E) and Annexin-V staining experiments (Fig. 4D) . Phenotypic analysis showed decreased percentages of CD1a + cells and monocytic cells ( For showed less tight cell cluster formation. This is evident from the observation that purification of I B -SR transduced clusters over a 1 x g human serum albumin gradient 34 failed to recover typical LC clusters (Fig. 4B) . In contrast, p100 N (or RelB) did not influence homotypic LC clustering (data not shown). Therefore, efficient transition of LC precursors to LCs as well as homotypic LC adhesion requires classical NF-B signaling, whereas RelB-dependent signaling seems dispensable. Diminished DC differentiation by I B -SR is likely mediated by inhibition of TNF signaling. We confirmed this using a NF-B reporter assay.
We transduced the myelomonocytic cell line U937 with a NF-B-GFP reporter cassette, and generated a TNF -inducible subclone. We observed that I B but not p100 N suppressed NF-B activity in these cells in response to 48 hour TNF stimulation (Fig. 4C) . Together, these experiments show that p100 N and I B -SR substantially differ in the regulation of myeloid DC development.
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Ectopic RelB is not sufficient to induce DC maturation.
Enhancement of RelB expression as well as its nuclear translocation is a hallmark of human DC maturation in response to various stimuli. 23 However it is not known whether RelB is functionally involved in human DC maturation. The culture model used in our study yields high percentages of immature DC, which can be induced in a controlled manner to undergo DC maturation (CD40L for 48h 29 ). Therefore, this system is well suited to examine whether RelB overexpression might promote human DC maturation. Both DC subsets generated in serum-free medium show immature DC characteristics unless further stimulated with ligands that induce their maturation. We found that RelB transduced DCs resembled control cells in expression of DC maturationassociated marker molecules including CD86, CD80, HLA-DR, CD40, CD54 and CD83 (Fig. 5A) . Furthermore, RelB did not promote CD40L-induced DC maturation, as exemplified by comparable CD1a versus CD83 expression (Fig.   5B , n=14 independent experiments). Additionally, these CD40L stimulated cells did not differ phenotypically at earlier time-points (24 hours, data not shown). In line with these observations, the capacity of RelB transduced and control transduced CD1a + cells to stimulate allogeneic T cells was found to be equivalent (n=4, Fig. 5C ). We further observed that RelB inhibition by p100 N does not inhibit DC maturation, suggesting that RelB inhibition does not prevent human DC maturation (data not shown). Together, above-described experiments show that, enforced RelB expression in human CD34 + derived DC is not sufficient to only.
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RelB augments monopoiesis but not granulopoiesis.

Above data show, that RelB regulates generation of CD11b
+
CD14
+ monocytic DC intermediates ( Fig. 2 and Fig. 3 ). We analyzed whether this effect is specific to our DC culture system or whether RelB might generally affect human monopoiesis. Therefore, RelB and p100 N transduced CD34 + progenitors were stimulated with M-CSF plus IL-6, which cooperate in induction of human monopoiesis. 35 We found that overexpression of RelB increased whereas p100 N reduced percentages of CD11b
+ cells compared to control transduced cultures (Fig. 6A ). In line with above data (Fig. 2) ). Our data therefore support the concept that CD14 lo CD11b -precursors represent postcommitted shared human LC/DC/monocyte precursors. 9 We propose that RelB is involved in monocyte lineage fate decision of these precursors.
We showed that RelB inhibition impairs development of monocyte-derived DCs, while LC differentiation and DC cluster adhesion remained unchanged. This contrasts the effects of I B -SR, which inhibits classical NF-B signaling. We observed that both LC/DC differentiation, DC adhesion and myeloid progenitor cell proliferation are profoundly inhibited by I B -SR, as expected from previous studies. [36] [37] [38] [39] [40] [41] Therefore, therapeutic interference with non-classical NF-B/RelB signaling might represent an attractive strategy to modulate the antigenpresenting cell system in vivo in a DC subset-specific manner without simultaneously affecting all human DC functions and subsets. Interestingly, I B -SR inhibited cell differentiation and proliferation without detectably enhancing apoptosis of cultured primary cells. This seems to be contrary to previous reports, which showed I B -SR-induced cell death in many cell types. Several possible explanations for these differences might be envisioned. Among them are lower gene copy numbers in our study compared to previous studies and cell type specific differences. In line with this, primary CD34 + cells were previously reported to be more resistant to apoptosis induction by NF-B inhibition compared to phenotypically identical myeloid leukemia stem cells. 42 only. Conversely, several human DC subsets including human LCs, 31 pDCs 49, 50 or peripheral blood DCs 50 lack CD11b. We speculate that RelB might promote a monocyte-derived human DC pathway in vivo. These cells might give rise to DCs, which are specifically recruited to inflammatory sites. In this regard it is interesting to note that addition of serum favours the monocytic over the LC pathway from progenitors. 7, 9 Given that RelB is rapidly induced in response to serum stimulation, 51, 52 factors contained in serum might promote monocytic-DC differentiation from progenitors via a RelB-dependent mechanisms in vitro. Local stimuli in tissue microenvironments (e.g. in interstitium or dermis) might replace these under homeostatic conditions in vivo.
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We observed that ectopic RelB fails to enhance DC maturation. Previous studies described enhanced expression and nuclear translocation of RelB as a "hallmark" of human myeloid DC maturation in response to various stimuli that cause DC maturation. 23 These observations previously led to the speculation that RelB might functionally participate in myeloid DC maturation. Recently, it was shown that RelB is recruited to the nucleus with a markedly delayed kinetics compared to other NF-B members during human DC maturation, 24 resulting in an exchange of p65 and c-Rel by RelB-containing dimers over time, 53 Furthermore, it was demonstrated that binding of RelB to the IL-12p40 promoter correlates with a drop in RNApolII occupancy, which suggests that RelB contributes to transcriptional downregulation of this gene and potentially other DC-related genes. 53 Given this delayed kinetics, together with our observations that RelB overexpression fails to promote human DC maturation, it is unlikely that RelB is involved in initiating DC maturation. Instead, RelB might play a so far unrecognized regulatory role in DCs, which have already undergone maturation.
Interestingly, RelB inhibition by p100 N did not impair DC maturation (data not shown), suggesting that RelB is not required for DC maturation. This is in line with the observation that monocyte-derived DCs, in which the non-classical NF-B pathway is inhibited by adenoviral expression of dominant negative NF-B inducing kinase (NIK), are still capable of effective T-cell activation in an allogeneic MLR. 54 It should be taken into account that RelB might influence antigen-presenting functions in vivo in mice because of perturbations in DC subset frequencies that differ in antigen-presentation functions.
The observed RelB-dependent effects seem to be restricted to certain differentiation stages, and it must be considered that cultures of CD34 + cells represent heterogeneous populations comprising cells at distinct stages of differentiation. For detailed biochemical studies, it will be critical to establish more homogenous primary cell systems that selectively mimic these transition steps. In addition it has to be considered that RelB-dependent enhancement of For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From
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